Hi, my name is Ping Zhang.
I'm a senior economist from the Division of Diabetes Translation,
Centers for Disease Control and Prevention in the United States.
If you have any questions regarding this presentation,
please send me an email at pzhang@CDC.gov.
In this presentation, I'm going to talk about
economic and social costs of diabetes.
Here is a brief outline for my presentation.
I will describe the cost of diabetes from 4 different perspectives—
the cost borne by persons with diabetes and their families,
employer or business,
health care system, and society as a whole.
For each perspective, I will describe the cost in 2 different terms—
economic terms, which measure the cost in monetary value—
non-economic or social terms, which measure the cost in health terms,
such as mortality and health-related quality of life,
or other terms, such as social justice.
As the cost estimate from each perspective can be varied,
but country citing depends on many factors—
such as country's income level, healthcare utilization patterns,
and the cost of service, healthcare finance and tax structure.
All the estimates I presented here
are based on the current U.S. situation
unless I specify.
The cost of diabetes for a person with the disease and their families—
in economic terms, the cost can be divided into 3 categories.
Loss in personal or family income,
higher medical expenditures,
and higher non-medical expenditures,
all in comparison with a similar person without diabetes.
In non-economic terms,
the cost can be measured in terms of mortality—
that is the loss of life years—
and the morbidities—that is a lower quality of life.